12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effect of Transport Time on the Use of Reperfusion Therapy for Patients with Acute Ischemic Stroke in Korea

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          We investigated the association between geographic proximity to hospitals and the administration rate of reperfusion therapy for acute ischemic stroke.

          Methods

          We identified patients with acute ischemic stroke who visited the hospital within 12 hours of symptom onset from a prospective nationwide multicenter stroke registry. Reperfusion therapy was classified as intravenous thrombolysis (IVT), endovascular therapy (EVT), or combined therapy. The association between the proportion of patients who were treated with reperfusion therapy and the ground transport time was evaluated using a spline regression analysis adjusted for patient-level characteristics. We also estimated the proportion of Korean population that lived within each 30-minute incremental service area from 67 stroke centers accredited by the Korean Stroke Society.

          Results

          Of 12,172 patients (mean age, 68 ± 13 years; men, 59.7%) who met the eligibility criteria, 96.5% lived within 90 minutes of ground transport time from the admitting hospital. The proportion of patients treated with IVT decreased significantly when stroke patients lived beyond 90 minutes of the transport time ( P = 0.006). The proportion treated with EVT also showed a similar trend with the transport time. Based on the residential area, 98.4% of Korean population was accessible to 67 stroke centers within 90 minutes.

          Conclusion

          The use of reperfusion therapy for acute stroke decreased when patients lived beyond 90 minutes of the ground transport time from the hospital. More than 95% of the South Korean population was accessible to 67 stroke centers within 90 minutes of the ground transport time.

          Graphical Abstract

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct

          The effect of endovascular thrombectomy that is performed more than 6 hours after the onset of ischemic stroke is uncertain. Patients with a clinical deficit that is disproportionately severe relative to the infarct volume may benefit from late thrombectomy.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging

            New England Journal of Medicine, 378(8), 708-718
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

              The etiology of ischemic stroke affects prognosis, outcome, and management. Trials of therapies for patients with acute stroke should include measurements of responses as influenced by subtype of ischemic stroke. A system for categorization of subtypes of ischemic stroke mainly based on etiology has been developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST). A classification of subtypes was prepared using clinical features and the results of ancillary diagnostic studies. "Possible" and "probable" diagnoses can be made based on the physician's certainty of diagnosis. The usefulness and interrater agreement of the classification were tested by two neurologists who had not participated in the writing of the criteria. The neurologists independently used the TOAST classification system in their bedside evaluation of 20 patients, first based only on clinical features and then after reviewing the results of diagnostic tests. The TOAST classification denotes five subtypes of ischemic stroke: 1) large-artery atherosclerosis, 2) cardioembolism, 3) small-vessel occlusion, 4) stroke of other determined etiology, and 5) stroke of undetermined etiology. Using this rating system, interphysician agreement was very high. The two physicians disagreed in only one patient. They were both able to reach a specific etiologic diagnosis in 11 patients, whereas the cause of stroke was not determined in nine. The TOAST stroke subtype classification system is easy to use and has good interobserver agreement. This system should allow investigators to report responses to treatment among important subgroups of patients with ischemic stroke. Clinical trials testing treatments for acute ischemic stroke should include similar methods to diagnose subtypes of stroke.
                Bookmark

                Author and article information

                Journal
                J Korean Med Sci
                J Korean Med Sci
                JKMS
                Journal of Korean Medical Science
                The Korean Academy of Medical Sciences
                1011-8934
                1598-6357
                09 March 2021
                22 March 2021
                : 36
                : 11
                : e77
                Affiliations
                [1 ]Department of Neurology, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea.
                [2 ]Institute of Medical Science, Jeju National University, Jeju, Korea.
                [3 ]Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
                [4 ]Department of Neurology, Eulji University Hospital, Daejeon, Korea.
                [5 ]Department of Neurology, Eulji General Hospital, Eulji University, Seoul, Korea.
                [6 ]Department of Neurology, Seoul Medical Center, Seoul, Korea.
                [7 ]Department of Neurology, Ilsan Paik Hospital, Inje University, Goyang, Korea.
                [8 ]Department of Neurology, Soonchunhyang University College of Medicine, Seoul, Korea.
                [9 ]Department of Neurology, Yeungnam University Hospital, Daegu, Korea.
                [10 ]Department of Neurology, Dongguk University Ilsan Hospital, Goyang, Korea.
                [11 ]Department of Neurology, Dong-A University College of Medicine, Busan, Korea.
                [12 ]Department of Neurology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.
                [13 ]Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Korea.
                [14 ]Clinical Research Center, Asan Medical Center, Seoul, Korea.
                [15 ]Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
                Author notes
                Address for Correspondence: Jay Chol Choi, MD, PhD. Department of Neurology, Jeju National University, Aran 13-gil 15, Jeju 63241, Republic of Korea. jaychoi@ 123456jejunu.ac.kr
                Author information
                https://orcid.org/0000-0002-3550-2196
                https://orcid.org/0000-0002-4166-6023
                https://orcid.org/0000-0002-4176-0941
                https://orcid.org/0000-0003-0051-1997
                https://orcid.org/0000-0001-5715-6610
                https://orcid.org/0000-0001-8622-7000
                https://orcid.org/0000-0002-4199-3024
                https://orcid.org/0000-0002-5148-1663
                https://orcid.org/0000-0002-7843-1148
                https://orcid.org/0000-0003-2663-7483
                https://orcid.org/0000-0001-8643-0797
                https://orcid.org/0000-0002-9339-6539
                https://orcid.org/0000-0002-1049-5196
                https://orcid.org/0000-0003-4028-8339
                https://orcid.org/0000-0002-3885-981X
                https://orcid.org/0000-0001-8194-3462
                https://orcid.org/0000-0002-8095-6517
                Article
                10.3346/jkms.2021.36.e77
                7985286
                33754510
                d081721e-3051-488f-af05-8ef69173730c
                © 2021 The Korean Academy of Medical Sciences.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 18 October 2020
                : 11 January 2021
                Funding
                Funded by: Jeju National University Hospital, CrossRef https://doi.org/10.13039/501100008126;
                Categories
                Original Article
                Neuroscience

                Medicine
                ischemic stroke,reperfusion,thrombolysis,endovascular treatment,utilization
                Medicine
                ischemic stroke, reperfusion, thrombolysis, endovascular treatment, utilization

                Comments

                Comment on this article